Savara Inc.

SVRA·NasdaqGS·Healthcare
Compare
4.6600−0.0900 (−1.89%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close4.7500
Open4.8400
Day range4.46004.8800
52-week range3.86007.0050
Off day high−4.51%
Off 52-week high−33.48%
Volume3.56M
Avg. volume (3M)2.03M
Market cap957.44M
EPS (TTM)-0.5800
Forward P/E-12.70
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.20
Shares outstanding205.46M
Short interest16.35% of float
Earnings dateNov 11, 2026 (est.)
Analyst target11.0556
Profit margin0.00%

Against its peers

Compare in full ›
SVRA DMRA VOR AGMB 0RC6.IL SLDB
Market cap 957.44M 1.42B 1.24B 337.35M 1.22B 699.11M
P/E (TTM) — — 0.1 — 60.6 —
Forward P/E -12.7 -10.6 -5.7 -3.4 — -3.8
Price/book 8.2 -0.2 -9.0 2.7 5.7 2.9
Dividend yield — — — — 2.09% —
1-year change +17.09% +294.16% −5.02% −53.24% −8.11% +54.69%
Today −1.89% +3.89% +1.31% 0.00% +1.51% +3.82%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Related companies

Compare ›

The businesses closest to Savara's by what they do, from their descriptions, with the same industry weighted in.

Company Mkt cap Price Today
Damora Therapeutics, Inc.DMRA · Biotechnology 1.42B 22.94 +3.89%
Vor Biopharma Inc.VOR · Biotechnology 1.24B 20.12 +1.31%
AgomAb Therapeutics NVAGMB · Biotechnology 337.35M 6.85 0.00%
Pharma Mar, S.A.0RC6.IL · Biotechnology 1.22B 67.25 +1.51%
Solid Biosciences Inc.SLDB · Biotechnology 699.11M 6.52 +3.82%
Zevra Therapeutics, Inc.ZVRA · Biotechnology 663.32M 11.17 +8.87%
MannKind CorporationMNKD · Biotechnology 1.26B 3.9300 +5.36%
Avalyn Pharma Inc.AVLN · Biotechnology 1.22B 27.47 +2.46%

Also based in Yardley, Pennsylvania, then elsewhere in Pennsylvania.

Company Mkt cap Price Today
Smart Sand, Inc.SND · Yardley, PA 185.28M 4.3700 −6.62%
Comcast CorporationCMCSA · Philadelphia, PA 88.24B 24.85 +4.99%
The Kraft Heinz CompanyKHC · Pittsburgh, PA 30.17B 25.44 +3.75%
The PNC Financial Services Group, Inc.PNC · Pittsburgh, PA 92.74B 233.45 +1.76%
Howmet Aerospace Inc.HWM · Pittsburgh, PA 84.92B 213.56 −4.28%
Air Products and Chemicals, Inc.APD · Allentown, PA 71.01B 318.87 +1.89%
Westinghouse Air Brake Technologies CorporationWAB · Pittsburgh, PA 49.50B 294.97 +1.09%
Alcoa CorporationAA1.MX · Pittsburgh, PA 200.09B 758.00 +4.12%

The stocks whose daily moves over the past year went most closely with Savara's: the correlation of their daily returns, where 1 would be moving as one.

Company Mkt cap Price Today
Cullinan Therapeutics, Inc.CGEM · Correlation 0.38 767.61M 12.49 −20.70%
Damora Therapeutics, Inc.DMRA · Correlation 0.34 1.42B 22.94 +3.89%
Solid Biosciences Inc.SLDB · Correlation 0.33 699.11M 6.52 +3.82%
Vor Biopharma Inc.VOR · Correlation 0.32 1.24B 20.12 +1.31%
Zevra Therapeutics, Inc.ZVRA · Correlation 0.31 663.32M 11.17 +8.87%

What visitors to Savara's page also look at.

Company Mkt cap Price Today
Aquestive Therapeutics, Inc.AQST 476.94M 3.8000 −2.06%
Solid Biosciences Inc.SLDB 699.11M 6.52 +3.82%
Synlogic, Inc.SYBX 12.25M 1.0000 0.00%
Xeris Biopharma Holdings, Inc.XERS 1.91B 10.46 +1.06%
Ovid Therapeutics Inc.OVID 535.12M 2.7400 +14.17%

From the 4SEARCH.business instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.

Latest news

All SVRA news ›
markets.ft.com··2 outletsPositive

Savara Presented New Data Showing Molgramostim Inhalation Solution (Molgramostim) Treatment Effects in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Patients with Mild Diffusion Impairment – Company Announcement - FT.com

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the CHEST 2026 Annual Meeting in Phoenix, Arizona. The ... -- Post-Hoc Analysis of the Phase…

BMYAZN
More from 1 other outlet
Markets Daily·Negative

Savara (SVRA) – Analysts’ Weekly Ratings Updates

Several analysts have recently updated their ratings and price targets for Savara (NASDAQ: SVRA): 10/15/2026 – Savara had its “sell (d-)” rating reaffirmed by Weiss Ratings. 10/7/2026 – Savara was given a new $10.00 price target by Royal…

SVRARYMSC

From the 4Search news index, newest first.

In the news

4mentions in 30 days
4with it in the headline
Negativesentiment

Mentioned with

Morgan Stanley3Royal Bank of Canada2Scotiabank2TD Cowen2Weiss Ratings2Zacks Research2Alibaba1Amazon1

People in the coverage

Kim Johansen3Matt Pauls3Sarita Garza3Savara3Danessa Lincoln2HC Wainwright2

Themes

Avpt1Biotech1Cbre1Communication Service1Consensus1Copd1Data1EPS1

Most coverage from

  1. themarketsdaily.com2
  2. markets.ft.com1
  3. tikr.com1

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance